Wednesday, April 24, 2024

How Spectrum + Could Potentially Better the Lives of Children With Autism

Autism Spectrum Disorder (ASD) remains one of the most prevalent conditions in children today across the United States. Despite the advancements made in modern medicine, autism remains an incurable condition. Patients and their families can only hope to regulate its adverse behavioral and emotional effects. In hopes of bettering the lives of ASD patients, Fitore Nutrition partnered with Vitro Biopharma to create Spectrum +, a premium formulation designed to supply the nutrition deficiencies among children with autism.

Fitore Nutrition has long established its reputation as a leading proponent in the medical industry. Besides Spectrum +, the company is behind several successful formulations developed with a team of highly-qualified doctors and scientists. Fitore Nutrition, led by the visionary brother-founding duo of Tanner (CEO) and Nathan (CFO) Haas, is the creator of Thought Calmer—which promotes relaxation, reduces stress, improves a person’s moods safely and naturally. It is also the formulator of Easy Sleep™, an all-natural sleep aid. 

Vitro Biopharma has also proven itself as an innovator focusing on stem cell research and technology. The company is the creator of Fitore Stemulife™, a patent-pending formulation of natural ingredients that activates stem cells within the body to promote optimal health and proper DNA repair.

Together, Fitore Nutrition and Vitro Biopharma have discovered another breakthrough that could potentially help children with autism across the globe. Statistics reveal that one out of 68 American children have autism. Some show signs of it in their early formative years, apparent with the abnormalities in their communication and social skills. Others manifest the symptoms, later on, making ASD unpredictable and, for some, unavoidable.

Without a cure, autism remains manageable only through therapies and behavioral, educational support. It does not only affect the patient but also takes a toll on their families. Furthermore, studies have revealed that autism is rising at a rate of between 10% to 17% annually. Autism is even more prevalent than childhood cancer, juvenile diabetes, and childhood AIDS combined. Existing medical interventions for ASD today usually target symptomatology, but it is not enough to ease the child’s discomfort and address extreme effects.

Several diagnoses state that autism is a result of multiple genetic factors, but the environment a mother faces during pregnancy might also affect the baby’s health. Other researchers have also gathered evidence over the past three decades that autism may be a product of inflammation of the central nervous system. For this reason, Fitore Nutrition and Vitro Biopharma developed Spectrum + using stem cell therapy because of its ability to mediate inflammation. 

Fitore Nutrition and Vitro Biopharma share that preliminary studies demonstrate that Spectrum + addresses core symptoms, such as social impairment and various stereotyped activities including hyperactivity, anxiety and impaired cognitive function. 

The molecular mechanisms in Spectrum + also restored and normalized the central and peripheral immune alteration and oxidative stress markers. Furthermore, the formulation generated new molecular mechanisms such as the expression of cortical gamma-aminobutyric acid neurons and certain types of miRNAs that regulate spine growth.

Spectrum + is formulated with the highest quality, natural ingredients. It contains no preservatives, no dairy, no artificial flavors, no nuts, and no GMOs. With the combination of the best ingredients, Fitore Nutrition and Vitro Biopharma were able to present a revolutionary formulation that can help in neurological development and DNA repair in children with Autism. Spectrum + was created to be anti-inflammatory and contains antioxidants. As it contains natural ingredients, Spectrum + is also safe for children with autism with all types of diets and sensitivities. 

Share this article

(Ambassador)

This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of New York Weekly.